Effects of ivabradine on the pulmonary vein electrical activity and modulation of pacemaker currents and calcium homeostasis

Yao Chang Chen, Kazuyoshi Suenari, Chen Chuan Cheng, Yung Kuo Lin, Yukiko Nakano, Yasuki Kihara, Shih Ann Chen, Yi Jen Chen

Research output: Contribution to journalArticle

30 Citations (Scopus)

Abstract

Effects of Ivabradine on Pulmonary Veins. Introduction: Ivabradine is a novel heart rate decreasing agent with selective and specific antagonist effects on the pacemaker current (I f). The aim of this study was to investigate the pharmacological effects of ivabradine on the pulmonary vein (PV) cardiomyocytes. Methods and Results: Whole-cell patch-clamp techniques and the indo-1 fluorimetric ratio technique were used to investigate the characteristics of the I f and intracellular calcium (Ca 2+ i) in single isolated rabbit PV cardiomyocytes with pacemaker activity before and after an ivabradine administration (0.3, 3, 10, and 30 μM). Ivabradine (0.3, 3, 10, and 30 μM) concentration dependently decreased the spontaneous activity by 6 ± 3%, 32 ± 6%, 49 ± 5%, and 85 ± 4%, and decreased the I f by 35 ± 8%, 47 ± 9%, 62 ± 5%, and 65 ± 7%, respectively, in PV cardiomyocytes. The decreased extent of the PV beating rate or I f by the different concentrations of ivabradine correlated well with the baseline PV beating rates. The IC 50 of the spontaneous activity and I f induced by ivabradine were 9.5 and 3.5 μM, respectively. Moreover, ivabradine (30 μM, but not 3 μM) decreased the Ca 2+ i transient in the PV cardiomyocytes and ivabradine (30 μM) decreased the L-type calcium current in the PV cardiomyocytes. Conclusion: Ivabradine decreased the I fs and Ca 2+ i transient in the PV cardiomyocytes, which may contribute to its inhibitory effects on the PV spontaneous activity.

Original languageEnglish
Pages (from-to)200-206
Number of pages7
JournalJournal of Cardiovascular Electrophysiology
Volume23
Issue number2
DOIs
Publication statusPublished - Feb 2012
Externally publishedYes

Fingerprint

ivabradine
Pulmonary Veins
Homeostasis
Calcium
Cardiac Myocytes
Patch-Clamp Techniques

Keywords

  • atrial fibrillation
  • calcium regulation
  • ivabradine
  • pacemaker current
  • pulmonary vein

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Physiology (medical)

Cite this

Effects of ivabradine on the pulmonary vein electrical activity and modulation of pacemaker currents and calcium homeostasis. / Chen, Yao Chang; Suenari, Kazuyoshi; Cheng, Chen Chuan; Lin, Yung Kuo; Nakano, Yukiko; Kihara, Yasuki; Chen, Shih Ann; Chen, Yi Jen.

In: Journal of Cardiovascular Electrophysiology, Vol. 23, No. 2, 02.2012, p. 200-206.

Research output: Contribution to journalArticle

Chen, Yao Chang ; Suenari, Kazuyoshi ; Cheng, Chen Chuan ; Lin, Yung Kuo ; Nakano, Yukiko ; Kihara, Yasuki ; Chen, Shih Ann ; Chen, Yi Jen. / Effects of ivabradine on the pulmonary vein electrical activity and modulation of pacemaker currents and calcium homeostasis. In: Journal of Cardiovascular Electrophysiology. 2012 ; Vol. 23, No. 2. pp. 200-206.
@article{f5f60f76ae4a499fab55e0eebb11a77f,
title = "Effects of ivabradine on the pulmonary vein electrical activity and modulation of pacemaker currents and calcium homeostasis",
abstract = "Effects of Ivabradine on Pulmonary Veins. Introduction: Ivabradine is a novel heart rate decreasing agent with selective and specific antagonist effects on the pacemaker current (I f). The aim of this study was to investigate the pharmacological effects of ivabradine on the pulmonary vein (PV) cardiomyocytes. Methods and Results: Whole-cell patch-clamp techniques and the indo-1 fluorimetric ratio technique were used to investigate the characteristics of the I f and intracellular calcium (Ca 2+ i) in single isolated rabbit PV cardiomyocytes with pacemaker activity before and after an ivabradine administration (0.3, 3, 10, and 30 μM). Ivabradine (0.3, 3, 10, and 30 μM) concentration dependently decreased the spontaneous activity by 6 ± 3{\%}, 32 ± 6{\%}, 49 ± 5{\%}, and 85 ± 4{\%}, and decreased the I f by 35 ± 8{\%}, 47 ± 9{\%}, 62 ± 5{\%}, and 65 ± 7{\%}, respectively, in PV cardiomyocytes. The decreased extent of the PV beating rate or I f by the different concentrations of ivabradine correlated well with the baseline PV beating rates. The IC 50 of the spontaneous activity and I f induced by ivabradine were 9.5 and 3.5 μM, respectively. Moreover, ivabradine (30 μM, but not 3 μM) decreased the Ca 2+ i transient in the PV cardiomyocytes and ivabradine (30 μM) decreased the L-type calcium current in the PV cardiomyocytes. Conclusion: Ivabradine decreased the I fs and Ca 2+ i transient in the PV cardiomyocytes, which may contribute to its inhibitory effects on the PV spontaneous activity.",
keywords = "atrial fibrillation, calcium regulation, ivabradine, pacemaker current, pulmonary vein",
author = "Chen, {Yao Chang} and Kazuyoshi Suenari and Cheng, {Chen Chuan} and Lin, {Yung Kuo} and Yukiko Nakano and Yasuki Kihara and Chen, {Shih Ann} and Chen, {Yi Jen}",
year = "2012",
month = "2",
doi = "10.1111/j.1540-8167.2011.02173.x",
language = "English",
volume = "23",
pages = "200--206",
journal = "Journal of Cardiovascular Electrophysiology",
issn = "1045-3873",
publisher = "Wiley-Blackwell",
number = "2",

}

TY - JOUR

T1 - Effects of ivabradine on the pulmonary vein electrical activity and modulation of pacemaker currents and calcium homeostasis

AU - Chen, Yao Chang

AU - Suenari, Kazuyoshi

AU - Cheng, Chen Chuan

AU - Lin, Yung Kuo

AU - Nakano, Yukiko

AU - Kihara, Yasuki

AU - Chen, Shih Ann

AU - Chen, Yi Jen

PY - 2012/2

Y1 - 2012/2

N2 - Effects of Ivabradine on Pulmonary Veins. Introduction: Ivabradine is a novel heart rate decreasing agent with selective and specific antagonist effects on the pacemaker current (I f). The aim of this study was to investigate the pharmacological effects of ivabradine on the pulmonary vein (PV) cardiomyocytes. Methods and Results: Whole-cell patch-clamp techniques and the indo-1 fluorimetric ratio technique were used to investigate the characteristics of the I f and intracellular calcium (Ca 2+ i) in single isolated rabbit PV cardiomyocytes with pacemaker activity before and after an ivabradine administration (0.3, 3, 10, and 30 μM). Ivabradine (0.3, 3, 10, and 30 μM) concentration dependently decreased the spontaneous activity by 6 ± 3%, 32 ± 6%, 49 ± 5%, and 85 ± 4%, and decreased the I f by 35 ± 8%, 47 ± 9%, 62 ± 5%, and 65 ± 7%, respectively, in PV cardiomyocytes. The decreased extent of the PV beating rate or I f by the different concentrations of ivabradine correlated well with the baseline PV beating rates. The IC 50 of the spontaneous activity and I f induced by ivabradine were 9.5 and 3.5 μM, respectively. Moreover, ivabradine (30 μM, but not 3 μM) decreased the Ca 2+ i transient in the PV cardiomyocytes and ivabradine (30 μM) decreased the L-type calcium current in the PV cardiomyocytes. Conclusion: Ivabradine decreased the I fs and Ca 2+ i transient in the PV cardiomyocytes, which may contribute to its inhibitory effects on the PV spontaneous activity.

AB - Effects of Ivabradine on Pulmonary Veins. Introduction: Ivabradine is a novel heart rate decreasing agent with selective and specific antagonist effects on the pacemaker current (I f). The aim of this study was to investigate the pharmacological effects of ivabradine on the pulmonary vein (PV) cardiomyocytes. Methods and Results: Whole-cell patch-clamp techniques and the indo-1 fluorimetric ratio technique were used to investigate the characteristics of the I f and intracellular calcium (Ca 2+ i) in single isolated rabbit PV cardiomyocytes with pacemaker activity before and after an ivabradine administration (0.3, 3, 10, and 30 μM). Ivabradine (0.3, 3, 10, and 30 μM) concentration dependently decreased the spontaneous activity by 6 ± 3%, 32 ± 6%, 49 ± 5%, and 85 ± 4%, and decreased the I f by 35 ± 8%, 47 ± 9%, 62 ± 5%, and 65 ± 7%, respectively, in PV cardiomyocytes. The decreased extent of the PV beating rate or I f by the different concentrations of ivabradine correlated well with the baseline PV beating rates. The IC 50 of the spontaneous activity and I f induced by ivabradine were 9.5 and 3.5 μM, respectively. Moreover, ivabradine (30 μM, but not 3 μM) decreased the Ca 2+ i transient in the PV cardiomyocytes and ivabradine (30 μM) decreased the L-type calcium current in the PV cardiomyocytes. Conclusion: Ivabradine decreased the I fs and Ca 2+ i transient in the PV cardiomyocytes, which may contribute to its inhibitory effects on the PV spontaneous activity.

KW - atrial fibrillation

KW - calcium regulation

KW - ivabradine

KW - pacemaker current

KW - pulmonary vein

UR - http://www.scopus.com/inward/record.url?scp=84857030973&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84857030973&partnerID=8YFLogxK

U2 - 10.1111/j.1540-8167.2011.02173.x

DO - 10.1111/j.1540-8167.2011.02173.x

M3 - Article

VL - 23

SP - 200

EP - 206

JO - Journal of Cardiovascular Electrophysiology

JF - Journal of Cardiovascular Electrophysiology

SN - 1045-3873

IS - 2

ER -